# Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study

> **NCT02255617** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 4 (actual)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplant

## Key facts

- **NCT ID:** NCT02255617
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-23
- **Primary completion:** 2019-07-25
- **Final completion:** 2019-09-23
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02255617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02255617, "Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02255617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*